Close

Incyte (INCY), MorphoSys AG (MOR) Doses First Patient in Phase 3 inMIND Study

Go back to Incyte (INCY), MorphoSys AG (MOR) Doses First Patient in Phase 3 inMIND Study
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 56.83 -0.29 (0.51%)
Previous Close $57.12    52 Week High $118.49 
Open $57.25    52 Week Low $55.00 
Day High $57.40    P/E N/A 
Day Low $56.61    EPS $-0.56 
Volume 831,584       

(AMEX: MDAX) Delayed: 0.62 --0 (-0%)
Previous Close $0.62    52 Week High
Open $0.62    52 Week Low
Day High $0.62    P/E N/A 
Day Low $0.62    EPS
Volume      

Morgan Stanley Capital Protected Notes for S&P 500 Index (NASDAQ: MOR) Delayed: 18.12 -0.02 (0.11%)
Previous Close $18.14    52 Week High $13.71 
Open $18.15    52 Week Low $9.64 
Day High $18.16    P/E N/A 
Day Low $18.10    EPS $0.00 
Volume 169,887